Instuitional Investor - Flagship Ventures Management, Inc.
Fund Profile
Filing Period:
| Fund Name: | Flagship Ventures Management, Inc. |
| Portfolio Value | $344,896,000 |
Top 13F Holdings
Filing Period:
| No. | Security | Ticker | Shares | Value (x$1000) | % Port |
|---|---|---|---|---|---|
| 1. | Denali Therapeutics Inc | 8,918,749 | $175,610 | 50.91% | |
| 2. | Seres Therapeutics Inc | 12,682,876 | $93,092 | 26.99% | |
| 3. | Syros Pharmaceuticals Inc | 3,204,437 | $41,594 | 12.05% | |
| 4. | Quanterix Corp | 2,030,495 | $34,600 | 10.03% | |
| 5. | Editas Medicine Inc | 0 | $0 | 0% |
